Richard Pham
Cleveland, OHNPI 1710478607
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 44.8% of the total. 2025 is the largest year on record at $6,542, more than ten times the $243 reported in 2021.
Across 153 payments — averaging $75.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$3K
- Biosense Webster, Inc.$991
- Abbott$859
- Pfizer$299
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$275
- plus $1K from 18 others
What the payments were for
- Travel & lodging$5,37146%
- Food & beverage$5,27746%
- Education$9038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 47 | $5,177 |
| Boston Scientific | 12 | $2,914 |
| Biosense Webster, Inc. | 14 | $991 |
| Abbott | 9 | $859 |
| Pfizer | 22 | $299 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $275 |
| E.r. Squibb & Sons, L.L.C. | 7 | $205 |
| Philips North America LLC | 1 | $190 |
| Boehringer Ingelheim | 6 | $112 |
| Lantheus Medical Imaging, Inc. | 4 | $99 |
| Medical Device Business Services, Inc. | 2 | $94 |
| Amgen | 3 | $55 |
| Sanofi | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Abiomed | 1 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| Merck | 1 | $22 |
| Edwards Lifesciences | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Atricure, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLIA MRI QUAD CRT-D SURESCAN$947
- Carto 3$633
- ENSITE$479
- Farapulse$299
- SelectSecure$252
- Micra$237
- (BQ9) Coronary IVUS$190
- ENSITE PRECISION$175
- CAMZYOS$106
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 32 | $240 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.